Benzinga | Apr 29, 2021 04:17PM EDT

Macrogenics Q1 EPS $(0.90) Misses $(0.61) Estimate, Sales $16.90M Up From $13.68M YoY

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.61) by 47.54 percent. This is a 1.1 percent increase over losses of $(0.91) per share from the same period last year. The company reported $16.90 million in sales this quarter. This is a 23.52 percent increase over sales of $13.68 million the same period last year.